{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:41:09Z","timestamp":1791848469361,"version":"4.3.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of Milano","award":["CUP G42I14001030001"],"award-info":[{"award-number":["CUP G42I14001030001"]}]},{"DOI":"10.13039\/501100007158","name":"Fondazione Ricerca Molinette Onlus","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007158","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007364","name":"Fondazione CRT","doi-asserted-by":"publisher","award":["2015-2518"],"award-info":[{"award-number":["2015-2518"]}],"id":[{"id":"10.13039\/100007364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.antiviral.2016.09.002","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T20:45:49Z","timestamp":1473885949000},"page":"182-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity"],"prefix":"10.1016","volume":"134","author":[{"given":"Massimiliano","family":"Bissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8151-9124","authenticated-orcid":false,"given":"Elena","family":"Quaglino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Zanotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Illiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3923-9476","authenticated-orcid":false,"given":"Valeria","family":"Rolih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sole","family":"Pacchioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"De Giuli Morghen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Radaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.09.002_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/rmv.571","article-title":"New generation smallpox vaccines: a review of preclinical and clinical data","volume":"18","author":"Artenstein","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0264-410X(92)90411-C","article-title":"Potential use of nonreplicating vectors as recombinant vaccines","volume":"10","author":"Baxby","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib3","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1182\/blood-2005-11-4374","article-title":"Impact of vaccine-induced mucosal high-avidity CD8-CTLs in delay of AIDS viral dissemination from mucosa","volume":"107","author":"Belyakov","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2016.09.002_bib4","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.virusres.2013.09.016","article-title":"Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do notprotect mice against the highly pathogenic IHD-J vaccinia strain","volume":"178","author":"Bissa","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2016.09.002_bib5","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1016\/j.vaccine.2006.12.001","article-title":"Induction of secretory immunity and memory at mucosal surfaces","volume":"25","author":"Brandtzaeg","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/08820131003680369","article-title":"Function of mucosa-associated lymphoid tissue in antibody formation","volume":"39","author":"Brandtzaeg","year":"2010","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.antiviral.2016.09.002_bib7","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1016\/j.vaccine.2010.07.030","article-title":"A\u00a0protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge","volume":"28","author":"Buchman","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib8","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2016.09.002_bib9","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.vaccine.2007.12.059","article-title":"Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine","volume":"26","author":"Ferrier-Rembert","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib10","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/j.vaccine.2006.12.037","article-title":"Adjuvant enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges","volume":"25","author":"Fogg","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1165\/rcmb.2011-0070OC","article-title":"Mouse lung CD103 \u00fe and CD11 b high dendritic cells preferentially induce distinct CD4\u00fe T-cell responses","volume":"46","author":"Furuhashi","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib12","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1586\/erv.11.46","article-title":"The strategic use of novel smallpox vaccines in the post-eradication world","volume":"10","author":"Golden","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2016.09.002_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/1743-422X-8-441","article-title":"Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease","volume":"8","author":"Golden","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2016.09.002_bib14","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.4049\/jimmunol.1200799","article-title":"CD8 T cells are essential for recovery from a respiratory vaccinia virus infection","volume":"189","author":"Goulding","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib15","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit recombinant vaccine protects against monkeypox","volume":"177","author":"Heraud","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/mi.2013.45","article-title":"Antigen-bearing dendritic cells from the sublingual mucosa recirculate to distant systemic lymphoid organs to prime mucosal CD8 Tcells","volume":"7","author":"Hervouet","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/infdis\/jiq017","article-title":"Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge","volume":"203","author":"Hirao","year":"2011","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.002_bib18","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2016.09.002_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicitis appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.002_bib20","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.vaccine.2006.11.017","article-title":"Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge","volume":"25","author":"Hooper","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib21","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3201\/eid0703.017311","article-title":"Outbreak of human monkeypox, democratic republic of Congo, 1996 to 1997","volume":"7","author":"Hutin","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.002_bib22","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1016\/j.vaccine.2008.05.044","article-title":"US military service members vaccinated against smallpox in 2003 and 2004 experience a slightly higher risk of hospitalization postvaccination","volume":"26","author":"Jacobson","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib23","doi-asserted-by":"crossref","first-page":"9751","DOI":"10.1128\/JVI.00816-14","article-title":"A\u00a0novel mode of poxvirus superinfection exclusion that prevents fusion of the lipid bilayers of viral and cellular membranes","volume":"88","author":"Laliberte","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1045-1870(03)00032-3","article-title":"Adverse events occurring after smallpox vaccination","volume":"14","author":"Lane","year":"2003","journal-title":"Semin. Pediatr. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.002_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00001432-200404000-00003","article-title":"Zoonotic poxvirus infections in humans","volume":"17","author":"Lewis-Jones","year":"2004","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.002_bib26","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.coi.2009.05.016","article-title":"Heterologous prime-boost vaccination","volume":"21","author":"Lu","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib27","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3201\/eid1801.110692","article-title":"Vaccinia virus zoonotic infection, S\u00e3o Paulo State, Brazil","volume":"18","author":"Megid","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.002_bib29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.vaccine.2010.10.064","article-title":"VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone","volume":"29","author":"Moise","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","article-title":"Smallpox vaccines: targets of protective immunity","volume":"239","author":"Moss","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2016.09.002_bib31","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1479-5876-11-95","article-title":"L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines","volume":"11","author":"Pacchioni","year":"2013","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.antiviral.2016.09.002_bib33","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1128\/JVI.00115-06","article-title":"Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function","volume":"80","author":"Panchanathan","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib34","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1038\/mtm.2015.18","article-title":"Mucosal derivery of a vectored RSV vaccine is safe and elicits protective immunity in rodens and nonhuman primates","volume":"2","author":"Pierantoni","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.antiviral.2016.09.002_bib35","first-page":"362","article-title":"Smallpox vaccines: from first to second to third generation","volume":"365","author":"Poland","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jviromet.2009.01.021","article-title":"Construction and characterization of recombinant fowlpox viruses expressing human papilloma virus E6 and E7 oncoproteins","volume":"158","author":"Pozzi","year":"2009","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.antiviral.2016.09.002_bib37","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.vaccine.2006.11.009","article-title":"Prime-boost immunization with DNA, recombinant fowlpox virus and VLP(SHIV) elicit both neutralizing antibodies and IFNgamma-producing T cells against the HIV-envelope protein in mice that control env-bearing tumour cells","volume":"25","author":"Radaelli","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib38","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/0264-410X(94)90181-3","article-title":"Humoral and cell mediated immunity in rabbits immunized with live non replicating avipox recombinants expressing the HIV-1sf2 env gene","volume":"12","author":"Radaelli","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(03)00184-3","article-title":"Prior DNA immunization enhances immune response to dominant and subdominant viral epitopes induced by a fowlpox-based SIVmac vaccine in long-term slow-progressor macaques infected with SIVmac251","volume":"312","author":"Radaelli","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.002_bib40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1479-5876-8-40","article-title":"Fowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits","volume":"8","author":"Radaelli","year":"2010","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.antiviral.2016.09.002_bib41","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1016\/j.vaccine.2011.01.106","article-title":"A\u00a0comparative analysis of HIV-specific mucosal\/systemic T cell immunity and avidity following rDNA\/rFPV and poxvirus-poxvirus prime boost immunisations","volume":"29","author":"Ranasinghe","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib42","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1016\/j.vaccine.2006.04.023","article-title":"Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1","volume":"24","author":"Ranasinghe","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib43","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.4049\/jimmunol.178.4.2370","article-title":"Mucosal HIV-1 poxvirus prime-boost immunization induces high-avidity CD8 T cells with regime-dependent cytokine\/granzyme B profiles","volume":"178","author":"Ranasinghe","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib44","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa032299","article-title":"The detection of monkeypox in humans in the Western Hemisphere","volume":"350","author":"Reed","year":"2004","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.antiviral.2016.09.002_bib45","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1517\/17425247.2014.931936","article-title":"Intranasal formulations: promising strategy to deliver vaccines","volume":"11","author":"Riese","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.antiviral.2016.09.002_bib46","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.tim.2008.07.009","article-title":"Vaccinia virus morphogenesis and dissemination","volume":"16","author":"Roberts","year":"2008","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib47","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/JVI.60.2.436-449.1986","article-title":"Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the hindlll H genome fragment","volume":"60","author":"Rosel","year":"1986","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1863-2378.2007.00995.x","article-title":"Generalized fatal Cowpox virus infection in a cat with transmission to a human contact case","volume":"54","author":"Schulze","year":"2007","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.antiviral.2016.09.002_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1586\/14760584.4.1.63","article-title":"Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry","volume":"4","author":"Skinner","year":"2005","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.antiviral.2016.09.002_bib50","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib51","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1128\/JVI.78.13.7052-7060.2004","article-title":"Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses","volume":"78","author":"Snyder","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib52","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/viro.1993.1608","article-title":"Fowlpox virus host range restriction: gene expression, DNA replication, and morphogenesis in nonpermissive mammalian cells","volume":"197","author":"Somogyi","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.002_bib53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jviromet.2011.03.013","article-title":"Joint production of prime\/boost pairs of Fowlpox Virus and Modified Vaccinia Ankara recombinants carrying the same transgene","volume":"174","author":"Soprana","year":"2011","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.antiviral.2016.09.002_bib54","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/j.vaccine.2007.11.083","article-title":"Dynamics of acute and memory of mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes","volume":"26","author":"Srivastava","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib55","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1128\/JVI.02386-13","article-title":"The canarypox virus vector ALVAC induces distinct cytokine response scompared to the vaccinia virus-based vectors MVA and NYVAC in rhesus monkeys","volume":"88","author":"Teigler","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib56","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.virol.2014.09.004","article-title":"Different HIV pox viral vector-based vaccines and adjuvants can induce unique antigen presenting cells that modulate CD8 T cell avidity","volume":"468\u2013470","author":"Trivedi","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.002_bib57","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1016\/j.vaccine.2010.02.006","article-title":"Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity","volume":"28","author":"Vaine","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib58","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2340\/00015555-1227","article-title":"The Munich outbreak of cutaneous cowpox infection: transmission by infected pet rats","volume":"92","author":"Vogel","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.antiviral.2016.09.002_bib59","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1016\/j.vaccine.2008.04.073","article-title":"Heterologous HA DNA vaccine prime\u2013inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib60","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nm916","article-title":"Clonal vaccinia virus grown in cell culture as a new smallpox vaccine","volume":"9","author":"Weltzin","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2016.09.002_bib61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0166-3542(02)00195-X","article-title":"Smallpox: a potential agent of bioterrorism","volume":"57","author":"Whitley","year":"2003","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.09.002_bib62","first-page":"9","article-title":"Use of an in\u00a0vivo FTA assay to assess the magnitude, functional avidity and epitope variant cross-reactivity of T cell responses following HIV1-recombinant poxvirus vaccination","author":"Wijesundara","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2016.09.002_bib63","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0042-6822(86)90405-8","article-title":"Identification of antigenic determinants by polyclonal and hybridoma antibodies induced during the course of infection by vaccinia virus","volume":"148","author":"Wilton","year":"1986","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.002_bib64","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.vaccine.2006.09.046","article-title":"An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies","volume":"25","author":"Wiser","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.002_bib65","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1479-5876-9-190","article-title":"Construction and characterisation of a recombinant fowlpox virus that expresses the human papilloma virus L1 protein","volume":"9","author":"Zanotto","year":"2011","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.antiviral.2016.09.002_bib66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.antiviral.2010.07.005","article-title":"Canarypox and fowlpox viruses as recombinant vaccine vectors: a biological and immunological comparison","volume":"88","author":"Zanotto","year":"2010","journal-title":"Antivir. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T01:19:25Z","timestamp":1601083165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216303709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":66,"alternative-id":["S0166354216303709"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.09.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}